Does vitamin B12 deficiency cause macrocytosis by impairing DNA synthesis?

Vitamin B12 (cobalamin) is an essential cofactor for the enzyme methionine synthase, which plays a pivotal role in nucleotide synthesis. Deficiency in B12 initiates a cascade of hematological changes beginning at the molecular level, primarily affecting the maturation and survival of red blood cell precursors.

Mechanisms of macrocytosis and DNA impairment

The hallmark of B12 deficiency is the "folate trap," where folate becomes sequestered in the 5-methyl-tetrahydrofolate (THF) form. This prevents the regeneration of THF, which is required for the synthesis of thymidylate (dTMP)—a rate-limiting step in DNA replication.

• Nuclear-cytoplasmic asynchrony: While DNA synthesis is severely delayed or halted due to the dTMP shortage, RNA and protein synthesis in the cytoplasm proceed at a normal rate. This results in erythroblasts with immature nuclei and oversized, hemoglobin-rich cytoplasm.
• Macrocytic development: These cells eventually enter circulation as macro-ovalocytes, characterized by a mean corpuscular volume (MCV) typically exceeding 100 fL and reaching as high as 120–140 fL in severe cases.

Disruption of erythropoiesis and iron dynamics

The failure to complete DNA synthesis prevents many erythroid precursors from maturing, leading to ineffective erythropoiesis and intramedullary hemolysis.

• Intramedullary apoptosis: Rather than maturing into functional red blood cells, megaloblastic precursors often undergo apoptosis within the bone marrow. This is marked by significant elevations in lactate dehydrogenase (LDH), often exceeding 1000 U/L, and increased indirect bilirubin.
• Altered iron utilization: Because erythropoiesis is stalled, the iron that would normally be incorporated into hemoglobin is redirected. This results in elevated serum iron, ferritin, and transferrin saturation. Mechanistically, the erythropoietic stress may increase erythroferrone, which suppresses hepcidin to further enhance iron absorption and macrophage release, potentially leading to secondary iron overload.

Clinical implications

The metabolic shift caused by B12 deficiency can complicate the diagnosis of comorbid conditions.

• Masked iron deficiency: High ferritin levels resulting from poor utilization can mask a concurrent iron deficiency.
• Treatment response: Initiation of B12 therapy rapidly restores effective erythropoiesis, which causes a sudden drop in serum iron and ferritin as these stores are consumed for new red blood cell production.

Bottom line

Vitamin B12 deficiency causes macrocytosis by inducing a "folate trap" that impairs DNA synthesis, leading to large, immature red blood cells. This process triggers ineffective erythropoiesis and intramedullary hemolysis, which disrupts iron utilization, elevates serum iron markers, and can mask underlying iron deficiency until B12 stores are replenished.